Summary of Study ST001937

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR001226. The data can be accessed directly via it's Project DOI: 10.21228/M87H88 This work is supported by NIH grant, U2C- DK119886.


This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001937
Study TitleComprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules
Study SummaryThis study found evidence of early metabolic alterations that can distinguish SPNs from healthy controls, but not for benign and malignant SPNs (lung cancer in stage I), highlighting that malignant SPNs less than 3 cm in diameter are most likely lung cancer at some early stage that does not affect blood circulation. Benign SPNs seldom require excessive treatment, and the strategy to detecting and managing malignant SPNs is to perform periodic radiographic examinations and, if operable, bring patients to surgery as quickly as feasible to prevent cancer cells from entering the circulation.
China Pharmaceutical University
Last NameZhou
First NameWei
AddressNO.639 Longmian avenue, Jiangning District, Nanjing city, Jiangsu Province, China
Submit Date2021-09-11
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailGC-MS/LC-MS
Release Date2023-09-11
Release Version1
Wei Zhou Wei Zhou application/zip

Select appropriate tab below to view additional metadata details:


Collection ID:CO002008
Collection Summary:A total of 1160 plasma samples was obtained from healthy volunteers (n=280), benign SPNs (n=157, center 1=42; center 2=23; center 3=45; center 4=13; center 5=34) and malignant SPNs (stage I, n=723, center 1=118; center 2=105; center 3=139; center 4=33; center 5=328) patients enrolled from 5 independent centers.
Sample Type:Blood (plasma)